Multiple Sclerosis

The Pharmacy Times® Multiple Sclerosis Resource Center is a comprehensive resource for clinical news and expert insights on treatments for multiple sclerosis.

Latest News

Doctor examining MRI images of patient with multiple sclerosis at table in clinic, closeup - Image credit: New Africa | stock.adobe.com
FDA Grants Breakthrough Device Designation for Neuroimmune Modulation Platform To Treat MS

March 15th 2024

The platform is a first-of-its-kind therapeutic approach to promote remyelination among individuals with relapsing/remitting multiple sclerosis.

Metal Ion Chelators Hold Enormous Potential in Neurodegenerative Disorders
Metal Ion Chelators Hold Enormous Potential in Neurodegenerative Disorders

January 31st 2024

Image credit: Juan Gärtner | stock.adobe.com
Ocrelizumab Found to Suppress Immune Activity That Worsens Multiple Sclerosis Symptoms

October 16th 2023

Image credit: wladimir1804 - stock.adobe.com
FDA Approves First Biosimilar of Natalizumab for the Treatment of Relapsing Multiple Sclerosis

August 25th 2023

Credit: freshidea - stock.adobe.com.
Study: Ofatumumab Slows Worsening Disability in Patients With Relapsing Multiple Sclerosis

May 23rd 2023

Video Interviews
Podcasts
Latest CME Events & Activities

Treatment Advancements and Management Strategies in Bipolar Disorder to Mitigate Challenges to Patient Care

1.0 Credit / Neurology, Psychiatry

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

A Managed Care Focus on Assessing the Armamentarium for Multiple Sclerosis to Better Individualize Treatment

1.5 Credits / Neurology

View More

The Value of Early Intervention With Long-Acting Injectable Antipsychotics to Improve Adherence and Treatment of Schizophrenia

1.5 Credits / Neurology, Psychiatry

View More

The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights

1.0 Credit / Neurology

View More

Understanding the Role of IVIg and SCIg for the Management of CIDP: Information the Pharmacist Needs to Know to Optimize Care, featuring a Patient Perspective

1.5 Credits / Immunology, Neurology

View More

Rare and Treatment-Resistant Epilepsy Syndromes: Identifying and Addressing the Unmet Needs of Patients and Recognizing Opportunities for Pharmacist Intervention

1.5 Credits / Neurology

View More

Strategies for the Management and Treatment of ALS: The Value of Early Diagnosis and Clinical Intervention

3.0 Credits / Neurology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

1.0 Credit / Neurology

View More

Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances

2.0 Credits / Neurology

View More

Navigating the Use of Targeted Therapies and Individualizing Care for Patients With Ulcerative Colitis

1.5 Credits / Gastroenterology

View More

New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist

1.0 Credit / Neurology

View More

Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden

1.5 Credits / Neurology

View More

Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care

1.5 Credits / Neurology

View More

Advances in Pharmacotherapy for Excessive Daytime Sleepiness Due to Narcolepsy

2.0 Credits / Neurology

View More

The Role of Long-Term Care and Consultant Pharmacists in the Management of Tardive Dyskinesia

1.0 Credit / Neurology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

More News

© 2024 MJH Life Sciences

All rights reserved.